Novo immediately pushed back, calling it an unapproved, inauthentic and untested knockoff and signalling legal action over safety and regulatory concerns
(2) R T Dorr, R Lines, N Levine, C Brooks, et al (1996) Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study Life Sciences, 1996, Volume 58 (Issue 20), Pages 1777-84
Nyberg et al., 2005
Most men inject 1-2cc (200-400mg) per dose
For veterans in the study with a pre-existing substance-use disorder, starting a GLP-1 drug was associated with 31% fewer emergency department visits related to their addiction, 26% fewer hospital admissions, a halving of deaths, 39% fewer overdoses and a 25% reduction in suicidal ideation or attempts
Most are available as injection pens